Filing Details

Accession Number:
0001567619-23-003095
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-15 19:00:45
Reporting Period:
2023-02-13
Accepted Time:
2023-02-15 19:00:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528115 Annexon Inc. ANNX Pharmaceutical Preparations (2834) 275414423
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818522 Michael Overdorf C/O Annexon, Inc.
1400 Sierra Pt Pkwy, Bldg C, 2Nd Floor
Brisbane CA 94005
Evp & Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-13 1,501 $6.30 27,949 No 4 S Direct
Common Stock Disposition 2023-02-14 144 $6.30 27,805 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  2. This transaction was executed in multiple trades in prices ranging from $6.15 to $6.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Includes 7,575 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 15, 2022.
  4. Includes 17,709 restricted stock units.